Skip to main content

Fluidigm Secures Series E Financing

NEW YORK, June 27 (GenomeWeb News) - Fluidigm announced today it has secured series E funding from AllianceBernstein.


The company plans to use the money to develop and commercialize new applications for its proprietary integrated fluidic circuits technology, which has applications in genomics and proteomics.


Fluidigm's BioMark system uses IFCs for genetic and protein analysis, and the company said that it is developing further IFC-based systems "for rapid synthesis of radio-labeled imaging probes and preparation of nucleic acids for analysis."


Fluidigm declined to disclose the amount of the funding.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.